Drug Lobbyists Play Heartstrings To Argue 'Value'
This article was originally published in Scrip
Executive Summary
The two biggest Washington drug lobbyist groups – the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) –simultaneously launched advertising campaigns on Feb. 8 aimed at boosting the industry's image, which has taken a beating in recent months over criticism about the jacked up prices by some firms of their prescription medicines.